Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emilio Perucca

Showing results (41-50 of 306) with videos related to

Pageof 31
Sort By:
Epilepsia|July 6, 2020
Response: Cannabidiol antiseizure activity and its interactions with clobazam: "It's déjà vu all over again" Yogi BerraMeir Bialer, Emilio Perucca
Epilepsia|May 27, 2020
Does cannabidiol have antiseizure activity independent of its interactions with clobazam? An appraisal of the evidence from randomized controlled trialsMeir Bialer, Emilio Perucca
Current Opinion in Neurology|February 2, 2026
Novel pharmacological therapies in developmentPiero Perucca, Emilio Perucca
Expert Opinion on Drug Metabolism & Toxicology|June 4, 2015
CYP2C9 polymorphisms and phenytoin metabolism: implications for adverse effectsValentina Franco, Emilio Perucca
Expert Review of Neurotherapeutics|October 9, 2009
Challenges in the pharmacotherapy of the epilepsiesGiuliana Gatti, Emilio Perucca
Drugs|March 1, 2026
Antiseizure Medications that Did Not Reach the Epilepsy Market: An Assessment of Factors Contributing to Their Failed Clinical Development Over the Last Three DecadesMeir Bialer, Emilio Perucca
CNS Drugs|June 7, 2020
Critical Aspects Affecting Cannabidiol Oral Bioavailability and Metabolic Elimination, and Related Clinical ImplicationsEmilio Perucca, Meir Bialer
BMJ (Clinical Research Ed.)|November 20, 2004
Revisiting phenobarbital for epilepsyRajendra Kale, Emilio Perucca
Current Opinion in Neurology|November 16, 2004
Epilepsy after head injuryRaimondo D'Ambrosio, Emilio Perucca
Expert Review of Neurotherapeutics|September 2, 2015
The pharmacogenomics of epilepsyValentina Franco, Emilio Perucca
Pageof 31

Showing results (41-50 of 306) with videos related to

Sort By:
Pageof 31
Epilepsia|July 6, 2020
Response: Cannabidiol antiseizure activity and its interactions with clobazam: "It's déjà vu all over again" Yogi BerraMeir Bialer, Emilio Perucca
Epilepsia|May 27, 2020
Does cannabidiol have antiseizure activity independent of its interactions with clobazam? An appraisal of the evidence from randomized controlled trialsMeir Bialer, Emilio Perucca
Current Opinion in Neurology|February 2, 2026
Novel pharmacological therapies in developmentPiero Perucca, Emilio Perucca
Expert Opinion on Drug Metabolism & Toxicology|June 4, 2015
CYP2C9 polymorphisms and phenytoin metabolism: implications for adverse effectsValentina Franco, Emilio Perucca
Expert Review of Neurotherapeutics|October 9, 2009
Challenges in the pharmacotherapy of the epilepsiesGiuliana Gatti, Emilio Perucca
Drugs|March 1, 2026
Antiseizure Medications that Did Not Reach the Epilepsy Market: An Assessment of Factors Contributing to Their Failed Clinical Development Over the Last Three DecadesMeir Bialer, Emilio Perucca
CNS Drugs|June 7, 2020
Critical Aspects Affecting Cannabidiol Oral Bioavailability and Metabolic Elimination, and Related Clinical ImplicationsEmilio Perucca, Meir Bialer
BMJ (Clinical Research Ed.)|November 20, 2004
Revisiting phenobarbital for epilepsyRajendra Kale, Emilio Perucca
Current Opinion in Neurology|November 16, 2004
Epilepsy after head injuryRaimondo D'Ambrosio, Emilio Perucca
Expert Review of Neurotherapeutics|September 2, 2015
The pharmacogenomics of epilepsyValentina Franco, Emilio Perucca
Pageof 31